@article{6f5848f9e4b34a21ad52c06608c272f9,
title = "Real-world multicenter analysis of clinical outcomes and safety of meropenem-vaborbactam in patients treated for serious gram-negative bacterial infections",
abstract = "Fourty patients were treated with meropenem-vaborbactam (MEV) for serious Gram-negative bacterial (GNB) infections. Carbapenem-resistant Enterobacteriaceae (CRE) comprised 80.0% of all GNB infections. Clinical success occurred in 70.0% of patients. Mortality and recurrence at 30 days were 7.5% and 12.5%, respectively. One patient experienced a probable rash due to MEV.",
keywords = "Carbapenem-resistant Enterobacteriaceae, Gram-negative infections, Meropenem-vaborbactam, Multidrug-resistant",
author = "Sara Alosaimy and Jorgensen, {Sarah C.J.} and Lagnf, {Abdalhamid M.} and Sarah Melvin and Mynatt, {Ryan P.} and Carlson, {Travis J.} and Garey, {Kevin W.} and David Allen and Veena Venugopalan and Michael Veve and Vasilios Athans and Stephen Saw and Yost, {Christine N.} and Davis, {Susan L.} and Rybak, {Michael J.}",
note = "Publisher Copyright: {\textcopyright} The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.",
year = "2020",
month = mar,
day = "1",
doi = "10.1093/ofid/ofaa051",
language = "English (US)",
volume = "7",
journal = "Open Forum Infectious Diseases",
issn = "2328-8957",
publisher = "Oxford University Press",
number = "3",
}